These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 27589832)
1. A directly negative interaction of miR-203 and ZEB2 modulates tumor stemness and chemotherapy resistance in nasopharyngeal carcinoma. Jiang Q; Zhou Y; Yang H; Li L; Deng X; Cheng C; Xie Y; Luo X; Fang W; Liu Z Oncotarget; 2016 Oct; 7(41):67288-67301. PubMed ID: 27589832 [TBL] [Abstract][Full Text] [Related]
2. miR-374a-CCND1-pPI3K/AKT-c-JUN feedback loop modulated by PDCD4 suppresses cell growth, metastasis, and sensitizes nasopharyngeal carcinoma to cisplatin. Zhen Y; Fang W; Zhao M; Luo R; Liu Y; Fu Q; Chen Y; Cheng C; Zhang Y; Liu Z Oncogene; 2017 Jan; 36(2):275-285. PubMed ID: 27270423 [TBL] [Abstract][Full Text] [Related]
3. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells. Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715 [TBL] [Abstract][Full Text] [Related]
4. MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma. Jiang N; Jiang X; Chen Z; Song X; Wu L; Zong D; Song D; Yin L; Wang D; Chen C; Bian X; He X J Exp Clin Cancer Res; 2017 Oct; 36(1):138. PubMed ID: 28982387 [TBL] [Abstract][Full Text] [Related]
5. Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway. Yu C; Chen L; Yie L; Wei L; Wen T; Liu Y; Chen H Oncol Rep; 2015 May; 33(5):2402-10. PubMed ID: 25738652 [TBL] [Abstract][Full Text] [Related]
6. miR-184 Inhibits Tumor Invasion, Migration and Metastasis in Nasopharyngeal Carcinoma by Targeting Notch2. Zhu HM; Jiang XS; Li HZ; Qian LX; Du MY; Lu ZW; Wu J; Tian XK; Fei Q; He X; Yin L Cell Physiol Biochem; 2018; 49(4):1564-1576. PubMed ID: 30223264 [TBL] [Abstract][Full Text] [Related]
7. The effects of microRNA-98 inhibits cell proliferation and invasion by targeting STAT3 in nasopharyngeal carcinoma. Liu J; Chen W; Chen Z; Wen J; Yu H; Wang F; Wu L; He X Biomed Pharmacother; 2017 Sep; 93():869-878. PubMed ID: 28724212 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA‑30a regulates cell proliferation, migration, invasion and apoptosis in human nasopharyngeal carcinoma via targeted regulation of ZEB2. Chen X; Li J; Zhang S; Xu W; Shi D; Zhuo M; Liang S; Lei W; Xie C Mol Med Rep; 2019 Aug; 20(2):1672-1682. PubMed ID: 31257481 [TBL] [Abstract][Full Text] [Related]
9. Knockdown of long non-coding RNA TUG1 suppresses nasopharyngeal carcinoma progression by inhibiting epithelial-mesenchymal transition (EMT) via the promotion of miR-384. Qian W; Ren Z; Lu X Biochem Biophys Res Commun; 2019 Jan; 509(1):56-63. PubMed ID: 30581000 [TBL] [Abstract][Full Text] [Related]
10. miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells. Zhang P; Lu X; Shi Z; Li X; Zhang Y; Zhao S; Liu H Gene; 2019 Aug; 710():103-113. PubMed ID: 31158447 [TBL] [Abstract][Full Text] [Related]
11. MiRNA-34a reversed TGF-β-induced epithelial-mesenchymal transition via suppression of SMAD4 in NPC cells. Huang G; Du MY; Zhu H; Zhang N; Lu ZW; Qian LX; Zhang W; Tian X; He X; Yin L Biomed Pharmacother; 2018 Oct; 106():217-224. PubMed ID: 29960168 [TBL] [Abstract][Full Text] [Related]
12. miR-186 regulates epithelial-mesenchymal transformation to promote nasopharyngeal carcinoma metastasis by targeting ZEB1. Tang L; Xiang Y; Zhou J; Li T; Jia T; Du G Braz J Otorhinolaryngol; 2024; 90(1):101358. PubMed ID: 37989078 [TBL] [Abstract][Full Text] [Related]
13. Downregulated lncRNA UCA1 acts as ceRNA to adsorb microRNA-498 to repress proliferation, invasion and epithelial mesenchymal transition of esophageal cancer cells by decreasing ZEB2 expression. Wang P; Liu X; Han G; Dai S; Ni Q; Xiao S; Huang J Cell Cycle; 2019 Sep; 18(18):2359-2376. PubMed ID: 31387451 [No Abstract] [Full Text] [Related]
14. miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer. Ji H; Sang M; Liu F; Ai N; Geng C Pathol Res Pract; 2019 Apr; 215(4):697-704. PubMed ID: 30611621 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of miR-218 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling. Shi ZM; Wang L; Shen H; Jiang CF; Ge X; Li DM; Wen YY; Sun HR; Pan MH; Li W; Shu YQ; Liu LZ; Peiper SC; He J; Jiang BH Oncogene; 2017 May; 36(18):2577-2588. PubMed ID: 28192397 [TBL] [Abstract][Full Text] [Related]
16. miR-4792 inhibits epithelial-mesenchymal transition and invasion in nasopharyngeal carcinoma by targeting FOXC1. Li Y; Chen X Biochem Biophys Res Commun; 2015 Dec; 468(4):863-9. PubMed ID: 26585487 [TBL] [Abstract][Full Text] [Related]
17. miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion. Xia H; Ng SS; Jiang S; Cheung WK; Sze J; Bian XW; Kung HF; Lin MC Biochem Biophys Res Commun; 2010 Jan; 391(1):535-41. PubMed ID: 19931509 [TBL] [Abstract][Full Text] [Related]
18. CDK4 and miR-15a comprise an abnormal automodulatory feedback loop stimulating the pathogenesis and inducing chemotherapy resistance in nasopharyngeal carcinoma. Liu Z; Cheng C; Luo X; Xia Q; Zhang Y; Long X; Jiang Q; Fang W BMC Cancer; 2016 Mar; 16():238. PubMed ID: 26993269 [TBL] [Abstract][Full Text] [Related]
19. MiR-183 overexpression inhibits tumorigenesis and enhances DDP-induced cytotoxicity by targeting MTA1 in nasopharyngeal carcinoma. Wang G; Wang S; Li C Tumour Biol; 2017 Jun; 39(6):1010428317703825. PubMed ID: 28631568 [TBL] [Abstract][Full Text] [Related]
20. EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC. Yan Q; Zeng Z; Gong Z; Zhang W; Li X; He B; Song Y; Li Q; Zeng Y; Liao Q; Chen P; Shi L; Fan S; Xiang B; Ma J; Zhou M; Li X; Yang J; Xiong W; Li G Oncotarget; 2015 Dec; 6(39):41766-82. PubMed ID: 26497204 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]